{"collection_id":"ispy2","collection_name":"ISPY2","cancer_types":"Breast Cancer","tumor_locations":"Breast","species":"Human","subjects":719,"supporting_data":"Clinical, Image Analyses","description":"I-SPY 2 (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging And\nmoLecular analysis 2) is an ongoing, multi-center trial designed to quickly evaluate the efficacy of\nnew agents for breast cancer in neoadjuvant chemotherapy (NAC) setting. Women aged ≥18 years\ndiagnosed with locally advanced breast cancer (tumor size ≥2.5 cm) without distant metastasis are\neligible to enroll in the trial.\nPlease see the\nI-SPY 2 Breast Dynamic Contrast Enhanced MRI (I-SPY2 TRIAL) (https://doi.org/10.7937/TCIA.D8Z0-9T85)\nwiki page to learn more about the images and\nto\nobtain any supporting metadata for this collection.","patients":719,"studies":2688,"series":32411,"instances":5586493,"size_TB":1.746,"modalities":["MR","SEG"],"licenses":[{"license_short_name":"CC BY 4.0","series":32411,"size_TB":1.746}]}